World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
41226
World Ranking
10324
National Ranking
198

Lars Egevad publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lars Egevad sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 451 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lars Egevad D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Egevad sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lars Egevad is affiliated with the Karolinska Institute in Sweden and has a significant body of research primarily focused on medical fields related to prostate cancer and associated diagnostic and treatment methodologies. Their research spans topics related to urologic and reproductive health conditions, with a strong emphasis on prostate cancer diagnosis, treatment, and research.

The main fields of study of Lars Egevad include medicine, with notable subfields such as pulmonary and respiratory medicine, surgery, rheumatology, radiology, nuclear medicine and imaging, and artificial intelligence. This diverse expertise supports their involvement in multiple intersecting scientific areas.

Egevad has published extensively in a range of scientific journals, most frequently appearing in:

  • Pathology
  • The American Journal of Surgical Pathology
  • European Urology Open Science
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • European Urology

Their notable recent papers include:

  • Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study (2020) in The Lancet Oncology
  • Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only (2022) in New England Journal of Medicine
  • Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers (2020) in The American Journal of Surgical Pathology
  • Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade (2023) in EBioMedicine
  • Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells (2020) in Cell Death Discovery

Frequent co-authors collaborating with Lars Egevad are:

  • Hemamali Samaratunga
  • Brett Delahunt
  • Martin Eklund
  • Kimmo Kartasalo
  • Toyonori Tsuzuki

The primary research topics covered by Egevad include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Urologic and reproductive health conditions
  • AI in cancer detection
  • Bladder and Urothelial Cancer Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Renal cell carcinoma treatment

Best Publications

  • The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

    Jonathan I. Epstein;Lars Egevad;Mahul B. Amin;Brett Delahunt

  • The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma

    Geert J.L.H. van Leenders;Theodorus H. van der Kwast;David J. Grignon;Andrew J. Evans

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Gene expression profiling identifies clinically relevant subtypes of prostate cancer

    Jacques Lapointe;Chunde Li;John P. Higgins;Matt van de Rijn

  • A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

    Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

    M. Norberg;L. Egevad;L. Holmberg;P. Sparén

  • CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

    Ashley M. Miller;Kajsa Lundberg;Volkan Özenci;Alison H. Banham

  • Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.

    Peter Ström;Kimmo Kartasalo;Henrik Olsson;Leslie Solorzano

  • Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival

    I F Lissbrant;P Stattin;P Wikstrom;J E Damber

  • Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study

    Pär Stattin;Annika Bylund;Sabina Rinaldi;Carine Biessy

  • Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.

    Henrik Grönberg;Jan Adolfsson;Markus Aly;Tobias Nordström

  • International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins

    Puay Hoon Tan;Liang Cheng;John R Srigley;David Griffiths

  • Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

    Jonathan I. Epstein;Mahul Amin;Liliane Boccon-Gibod;Lars Egevad

  • Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

    H Ross-Adams;A D Lamb;M J Dunning;S Halim

  • International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume.

    Theo H van der Kwast;Mahul B Amin;Athanase Billis;Jonathan I Epstein

  • CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

    Martin Augsten;Christina Hägglöf;Eleonor Olsson;Claudia Stolz;Claudia Stolz

  • Protocol for the examination of specimens from patients with carcinoma of the prostate gland.

    John R. Srigley;Peter A. Humphrey;Mahul B. Amin;Sam S. Chang

  • Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference.

    Mahul B. Amin;Jonathan I. Epstein;Thomas M. Ulbright;Peter A. Humphrey

Frequent Co-Authors

Rodolfo Montironi
Rodolfo Montironi Marche Polytechnic University
Pär Stattin
Pär Stattin Uppsala University
Daniel M. Berney
Daniel M. Berney Barts Health NHS Trust
Henrik Grönberg
Henrik Grönberg Karolinska Institute
Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Peter A. Humphrey
Peter A. Humphrey Yale University
John R. Srigley
John R. Srigley University of Toronto
Glen Kristiansen
Glen Kristiansen University Hospital Bonn
Liang Cheng
Liang Cheng Brown University
Anders Bergh
Anders Bergh Umeå University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are many flexible online degree options that offer diverse career pathways in healthcare. Nursing professionals may explore asn to fnp programs, which provide a bridge from an Associate of Science in Nursing to becoming a Family Nurse Practitioner, expanding clinical expertise and job opportunities.

Nutrition is another important field in healthcare. The best online nutrition degree programs allow students to study dietetics, public health, or wellness, fully online, opening doors to roles in hospitals, community health, and corporate wellness.

Aspiring healthcare leaders can benefit from cahme accredited online healthcare administration programs that prepare graduates for management positions within medical facilities, focusing on business operations, health laws, and policy.

Registered nurses seeking career advancement may consider rn to bsn online no clinicals programs. These programs offer a convenient way to earn a Bachelor of Science in Nursing without additional in-person requirements.

With such a wide range of accredited online healthcare degrees, students can tailor their education toward specific interests and advance their careers in the growing medical field.

Best Scientists Citing Lars Egevad

Trending Scientists

Recently Published Articles